Author: Labib, Bisant A; Minhas, Bhawanjot K; Chigbu, DeGaulle I
Title: Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions Document date: 2020_3_17
ID: 6ehvyoug_8
Snippet: PVI has also shown value in treatment formulations. A large clinical trial for the use of 1.25% PVI ophthalmic solution in the treatment of pediatric conjunctivitis displayed efficacy in treatment of bacterial, chlamydial, and viral conjunctivitis. 40 Interestingly, a clinical trial looking at 0.5% PVI (in combination with artificial tears at pH 4.2 for enhanced tolerability) for the treatment of adenoviral keratoconjunctivitis found faster recov.....
Document: PVI has also shown value in treatment formulations. A large clinical trial for the use of 1.25% PVI ophthalmic solution in the treatment of pediatric conjunctivitis displayed efficacy in treatment of bacterial, chlamydial, and viral conjunctivitis. 40 Interestingly, a clinical trial looking at 0.5% PVI (in combination with artificial tears at pH 4.2 for enhanced tolerability) for the treatment of adenoviral keratoconjunctivitis found faster recovery from disease at two weeks, with three drops administered thrice daily. 34
Search related documents:
Co phrase search for related documents- artificial tear and ophthalmic solution: 1
- clinical trial and fast recovery: 1, 2
- clinical trial and treatment formulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date